U.S. flag

An official website of the United States government

GTR Home > Tests > Diamond-Blackfan anemia panel by next-generation sequencing (NGS)

Performance Characteristics



  • Entire test performed in-house

Analytical Validity


The analytic sensitivity of this methodology is >99%.


Not provided

Assay Limitation(s)


Mutations in regulatory regions or other untranslated regions are not detected by this test. Large deletions involving entire single exons or multiple exons, large insertions and genetic recombinational events may not be identified using these methods. Rare primer site variants may lead to erroneous results.

Proficiency Testing (PT)

Is proficiency testing performed for this test? Help
Method used for proficiency testingHelp

FDA Regulatory Clearances of the Test

FDA Category Designation
FDA exercises enforcement discretion

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.